{
  "main_header": {
    "sid": 10039310,
    "name": "Ambey Laborator.",
    "stock_name": "Ambey Laborator.",
    "full_name": "Ambey Laboratories Ltd",
    "name_url": "stocks-analysis/ambey-laborator",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "40.25",
    "chg": -0.3,
    "chgp": "-0.74%",
    "dir": -1,
    "prev_price": "40.55",
    "mcapval": "101.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "AMBEY",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE0M3I01029",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 4000,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ambey-laborator-10039310-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Ambey Laborator.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ambey-laborator-3704345",
        "imagepath": "",
        "date": "2025-11-15 00:35:05",
        "description": "Answer:\nThe historical performance of Ambey Laborator shows a steady growth in net sales and total operating income over the past four years, with figures rising from 84.60 Cr in Mar'22 to 131.27 Cr in Mar'25. The total expenditure has also increased, reflecting higher raw material costs, which rose from 69.91 Cr in Mar'22 to 118.83 Cr in Mar'25. Operating profit, excluding other income, has fluctuated slightly, peaking at 11.50 Cr in Mar'25, while profit before tax increased to 6.04 Cr in the same period. However, profit after tax saw a decline to 4.78 Cr in Mar'25 from 7.72 Cr in Mar'24. The company's equity capital has grown significantly, reaching 24.95 Cr in Mar'25, and total liabilities increased to 125.79 Cr, driven by a rise in short-term borrowings. Cash flow from operating activities has been negative, indicating challenges in cash generation, while cash flow from financing activities has provided..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3703778",
        "imagepath": "",
        "date": "2025-11-15 00:13:07",
        "description": "As of 14-Nov, Ambey Laboratories Ltd is experiencing a price increase, currently at 43.25, which reflects a rise of 3.3 or 8.26%. The stock has shown strong performance today, outperforming its sector by 8.78%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has significantly increased by 130.77% compared to the 5-day average, suggesting rising investor participation. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Ambey Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +12.05% compared to the Sensex's +1.64%. Despite this short-term strength, the stock has underperformed over longer periods, with a year-to-date decline of -32.16% against the Sensex's ..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3695389",
        "imagepath": "",
        "date": "2025-11-13 00:22:30",
        "description": "As of 12-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 36.95, reflecting a decrease of 1.6 or 4.15%. The stock has underperformed its sector by 2.75% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 74.58% compared to the 5-day average. Over the past week, the stock has decreased by 5.26%, and it has seen a substantial decline of 42.04% year-to-date, indicating ongoing challenges for the company.\n\nIn contrast, the broader market, represented by the Sensex, has shown positive movement, gaining 1.09% over the past week and 9.44% year-to-date. This stark difference highlights that while the market is performing well, Ambey Laboratories Ltd is struggling significantly, with its one-month return at -13.06% compared to th..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3668534",
        "imagepath": "",
        "date": "2025-11-03 23:57:40",
        "description": "As of 03-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 39.00, which reflects a decrease of 1.05 or 2.62%. The stock has underperformed its sector by 3.53% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 53.7% compared to the 5-day average. Over the past week, the stock has decreased by 1.89%, and it has shown a substantial decline of 38.82% year-to-date, indicating ongoing challenges for the company.\n\nIn the broader market context, the Sensex has increased by 8.96% year-to-date, highlighting a stark contrast between Ambey Laboratories Ltd's performance and that of the benchmark index. The stock's short-term performance, particularly its 1-month return of -6.92%, further emphasizes its struggles compared to the Sensex's..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3575706",
        "imagepath": "",
        "date": "2025-09-26 23:44:58",
        "description": "As of 26-Sep, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.3 or 3.06%. The stock has underperformed its sector today by 0.98%. In terms of returns, over the past week, the stock has gained 0.98%, while it has shown a modest increase of 0.24% over the past month. However, year-to-date, the stock is down significantly by 35.29%, and over the past year, it has decreased by 37.02%. The stock is currently trading higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with a delivery volume increase of 11.11% against the 5-day average, indicating some interest despite the overall decline.\n\nIn the broader market context, the Sensex has declined by 2.65% over the past week, while Ambey Laboratories has shown a positive return..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3568874",
        "imagepath": "",
        "date": "2025-09-24 23:52:00",
        "description": "As of 24-Sep, Ambey Laboratories Ltd is experiencing a price increase, with its current price at 44.35, reflecting a rise of 1.55 or 3.62%. The stock has shown strong performance today, outperforming its sector by 3.94%. Additionally, the stock's delivery volume has significantly increased, rising by 180% against the 5-day average, indicating rising investor participation. Over the past week, the stock has gained 7.78%, while it has also risen 11.71% over the past month. However, it is important to note that the stock has a year-to-date decline of 30.43% and a one-year decline of 35.30%, suggesting that while there is recent positive momentum, the stock has faced significant challenges over a longer period.\n\nIn the broader market context, the Sensex has declined by 1.08% over the past week and increased by only 0.75% over the past month, indicating that Ambey Laboratories Ltd's recent gains are occurring in..."
      },
      {
        "title": "Is Ambey Laborator. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ambey-laborator-overvalued-or-undervalued-3563301",
        "imagepath": "",
        "date": "2025-09-24 08:07:23",
        "description": "As of 23 September 2025, the valuation grade for Ambey Laborator. has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.92, an EV to EBITDA of 15.02, and a ROE of 6.26%. \n\nIn comparison to its peers, UPL has a PE Ratio of 38.05 and an EV to EBITDA of 9.17, while P I Industries is also very expensive with a PE of 34.2 and an EV to EBITDA of 24.36. Ambey Laborator.'s valuation appears stretched relative to these peers, highlighting its overvaluation status. Notably, over the past year, the stock has underperformed with a return of -39.55%, contrasting sharply with the Sensex's decline of only -2.97%...."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3562829",
        "imagepath": "",
        "date": "2025-09-24 00:00:02",
        "description": "As of 23-Sep, Ambey Laboratories Ltd is experiencing a price increase, currently at 42.80, reflecting a change of 1.2 or 2.88% upward. The stock has outperformed its sector by 4.08% today, and its current price is higher than the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Despite this positive movement, there has been a decline in investor participation, with delivery volume falling by 10.71% against the 5-day average. Year-to-date, the stock has seen a significant decline of 32.86%, contrasting with the Sensex's gain of 6.45% over the same period.\n\nIn the broader market context, the stock's short-term performance over the past week shows a slight increase of 0.12%, while the Sensex has decreased by 0.28%. This indicates that Ambey Laboratories Ltd is managing to maintain a positive trajectory in a generally unfavorable market environment. Howev..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3556063",
        "imagepath": "",
        "date": "2025-09-22 23:50:57",
        "description": "As of 22-Sep, Ambey Laboratories Ltd's stock price is rising, currently at 41.60, reflecting an increase of 0.75 or 1.84%. The stock has shown a positive performance today, outperforming its sector by 3.09%. Additionally, the stock's delivery volume has increased by 11.11% compared to the 5-day average, indicating rising investor participation. In terms of returns, the stock has gained 0.48% over the past week and 4.79% over the past month, although it remains down 34.75% year-to-date and 35.70% over the past year. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement.\n\nBroader Market Context: The stock's short-term performance has been slightly below the benchmark Sensex, which has increased by 0.53% over the past week and 1.34% over the past month. Despite the stock's recent gains, it has significantly underperformed the Sensex on a year-to-d..."
      }
    ],
    "total": 156,
    "sid": "10039310",
    "stock_news_url": "https://www.marketsmojo.com/news/ambey-laboratories-10039310"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Ambey Laborator.?

2025-11-15 00:35:05

Answer: The historical performance of Ambey Laborator shows a steady growth in net sales and total operating income over the past four years, with figures rising from 84.60 Cr in Mar'22 to 131.27 Cr in Mar'25. The total expenditure has also increased, reflecting higher raw material costs, which rose from 69.91 Cr in Mar'22 to 118.83 Cr in Mar'25. Operating profit, excluding other income, has fluctuated slightly, peaking at 11.50 Cr in Mar'25, while profit before tax increased to 6.04 Cr in the same period. However, profit after tax saw a decline to 4.78 Cr in Mar'25 from 7.72 Cr in Mar'24. The company's equity capital has grown significantly, reaching 24.95 Cr in Mar'25, and total liabilities increased to 125.79 Cr, driven by a rise in short-term borrowings. Cash flow from operating activities has been negative, indicating challenges in cash generation, while cash flow from financing activities has provided...

Read More

Why is Ambey Laborator. falling/rising?

2025-11-15 00:13:07

As of 14-Nov, Ambey Laboratories Ltd is experiencing a price increase, currently at 43.25, which reflects a rise of 3.3 or 8.26%. The stock has shown strong performance today, outperforming its sector by 8.78%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has significantly increased by 130.77% compared to the 5-day average, suggesting rising investor participation. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Ambey Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +12.05% compared to the Sensex's +1.64%. Despite this short-term strength, the stock has underperformed over longer periods, with a year-to-date decline of -32.16% against the Sensex's ...

Read More

Why is Ambey Laborator. falling/rising?

2025-11-13 00:22:30

As of 12-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 36.95, reflecting a decrease of 1.6 or 4.15%. The stock has underperformed its sector by 2.75% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 74.58% compared to the 5-day average. Over the past week, the stock has decreased by 5.26%, and it has seen a substantial decline of 42.04% year-to-date, indicating ongoing challenges for the company. In contrast, the broader market, represented by the Sensex, has shown positive movement, gaining 1.09% over the past week and 9.44% year-to-date. This stark difference highlights that while the market is performing well, Ambey Laboratories Ltd is struggling significantly, with its one-month return at -13.06% compared to th...

Read More

Why is Ambey Laborator. falling/rising?

2025-11-03 23:57:40

As of 03-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 39.00, which reflects a decrease of 1.05 or 2.62%. The stock has underperformed its sector by 3.53% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 53.7% compared to the 5-day average. Over the past week, the stock has decreased by 1.89%, and it has shown a substantial decline of 38.82% year-to-date, indicating ongoing challenges for the company. In the broader market context, the Sensex has increased by 8.96% year-to-date, highlighting a stark contrast between Ambey Laboratories Ltd's performance and that of the benchmark index. The stock's short-term performance, particularly its 1-month return of -6.92%, further emphasizes its struggles compared to the Sensex's...

Read More

Why is Ambey Laborator. falling/rising?

2025-09-26 23:44:58

As of 26-Sep, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.3 or 3.06%. The stock has underperformed its sector today by 0.98%. In terms of returns, over the past week, the stock has gained 0.98%, while it has shown a modest increase of 0.24% over the past month. However, year-to-date, the stock is down significantly by 35.29%, and over the past year, it has decreased by 37.02%. The stock is currently trading higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with a delivery volume increase of 11.11% against the 5-day average, indicating some interest despite the overall decline. In the broader market context, the Sensex has declined by 2.65% over the past week, while Ambey Laboratories has shown a positive return...

Read More

Why is Ambey Laborator. falling/rising?

2025-09-24 23:52:00

As of 24-Sep, Ambey Laboratories Ltd is experiencing a price increase, with its current price at 44.35, reflecting a rise of 1.55 or 3.62%. The stock has shown strong performance today, outperforming its sector by 3.94%. Additionally, the stock's delivery volume has significantly increased, rising by 180% against the 5-day average, indicating rising investor participation. Over the past week, the stock has gained 7.78%, while it has also risen 11.71% over the past month. However, it is important to note that the stock has a year-to-date decline of 30.43% and a one-year decline of 35.30%, suggesting that while there is recent positive momentum, the stock has faced significant challenges over a longer period. In the broader market context, the Sensex has declined by 1.08% over the past week and increased by only 0.75% over the past month, indicating that Ambey Laboratories Ltd's recent gains are occurring in...

Read More

Is Ambey Laborator. overvalued or undervalued?

2025-09-24 08:07:23

As of 23 September 2025, the valuation grade for Ambey Laborator. has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.92, an EV to EBITDA of 15.02, and a ROE of 6.26%. In comparison to its peers, UPL has a PE Ratio of 38.05 and an EV to EBITDA of 9.17, while P I Industries is also very expensive with a PE of 34.2 and an EV to EBITDA of 24.36. Ambey Laborator.'s valuation appears stretched relative to these peers, highlighting its overvaluation status. Notably, over the past year, the stock has underperformed with a return of -39.55%, contrasting sharply with the Sensex's decline of only -2.97%....

Read More

Why is Ambey Laborator. falling/rising?

2025-09-24 00:00:02

As of 23-Sep, Ambey Laboratories Ltd is experiencing a price increase, currently at 42.80, reflecting a change of 1.2 or 2.88% upward. The stock has outperformed its sector by 4.08% today, and its current price is higher than the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Despite this positive movement, there has been a decline in investor participation, with delivery volume falling by 10.71% against the 5-day average. Year-to-date, the stock has seen a significant decline of 32.86%, contrasting with the Sensex's gain of 6.45% over the same period. In the broader market context, the stock's short-term performance over the past week shows a slight increase of 0.12%, while the Sensex has decreased by 0.28%. This indicates that Ambey Laboratories Ltd is managing to maintain a positive trajectory in a generally unfavorable market environment. Howev...

Read More

Why is Ambey Laborator. falling/rising?

2025-09-22 23:50:57

As of 22-Sep, Ambey Laboratories Ltd's stock price is rising, currently at 41.60, reflecting an increase of 0.75 or 1.84%. The stock has shown a positive performance today, outperforming its sector by 3.09%. Additionally, the stock's delivery volume has increased by 11.11% compared to the 5-day average, indicating rising investor participation. In terms of returns, the stock has gained 0.48% over the past week and 4.79% over the past month, although it remains down 34.75% year-to-date and 35.70% over the past year. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement. Broader Market Context: The stock's short-term performance has been slightly below the benchmark Sensex, which has increased by 0.53% over the past week and 1.34% over the past month. Despite the stock's recent gains, it has significantly underperformed the Sensex on a year-to-d...

Read More

View All News